Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

Published:2013-04-18 Issue:5 Volume:73 Page:871-882
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Salgado Eva,Maneiro Jose R,Carmona Loreto,Gomez-Reino Juan J

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference81 articles.

1. The protein kinase complement of the human genome;Manning;Science,2002

2. Role of RNA-binding proteins in MAPK signal transduction pathway;Sugiura;Signal Transduct

3. The structural basis for control of eukaryotic protein kinases;Endicott;Annu Rev Biochem,2012

4. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?;Page;Arthritis Rheum,2010

5. Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders;Goldstein;J Med Chem,2010

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients;Frontiers in Pharmacology;2024-05-31

2. Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy;Rheumatology International;2022-08-18

3. The Developmental Transcription Factor p63 Is Redeployed to Drive Allergic Skin Inflammation through Phosphorylation by p38α;The Journal of Immunology;2022-06-15

4. Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis;Frontiers in Pharmacology;2022-03-02

5. Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases;Expert Opinion on Investigational Drugs;2022-02-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3